Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Telmisartan RM

    Virtual Booth

    Contact Supplier

    Telmisartan

    Virtual Booth

    Contact Supplier

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    TLS

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cadila Pharma Unveils Triple Therapy for BP Control
    Cadila Pharma Unveils Triple Therapy for BP Control

    10 Apr 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/cadila-pharma-launches-triple-combination-therapy-for-stronger-bp-control-19666

    INDPHARMAPOST
    10 Apr 2026
    Share Share
    National Pharmaceutical Pricing Authority Sets Retail Prices
    National Pharmaceutical Pricing Authority Sets Retail Prices

    27 Dec 2025

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=183261&sid=1

    PHARMABIZ
    27 Dec 2025
    Share Share
    TRIDENT Trial Shows BP Triple Combo Benefit in ICH Patients
    TRIDENT Trial Shows BP Triple Combo Benefit in ICH Patients

    23 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/23/3171872/0/en/TRIDENT-a-dedicated-stroke-outcomes-trial-in-patients-with-a-history-of-intracerebral-hemorrhage-ICH-demonstrates-the-potential-advantages-of-intensive-blood-pressure-treatment-wit.html

    GLOBENEWSWIRE
    23 Oct 2025
    Share Share
    Piramal Pharma Backs George Medicines in Hypertension Drug
    Piramal Pharma Backs George Medicines in Hypertension Drug

    29 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/piramal-pharma-solutions-supports-george-medicines-in-developing-its-new-drug-for-hypertension-widaplik-telmisartan-amlodipine-and-indapamide-302541305.html

    PR NEWSWIRE
    29 Aug 2025
    Share Share
    George Medicine, Azurity Pharma Ink Deal to Market WIDAPLIK in US
    George Medicine, Azurity Pharma Ink Deal to Market WIDAPLIK in US

    21 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/21/3118577/0/en/George-Medicines-signs-exclusive-licensing-agreement-with-Azurity-Pharmaceuticals-to-commercialize-WIDAPLIK-telmisartan-amlodipine-and-indapamide-tablets-in-the-US.html

    GLOBENEWSWIRE
    21 Jul 2025
    Share Share
    Veristat Congratulate George Medicine on FDA Approval of Widaplik
    Veristat Congratulate George Medicine on FDA Approval of Widaplik

    16 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250616203834/en/Veristat-Congratulates-George-Medicines-on-FDA-Approval-of-WIDAPLIK

    BUSINESSWIRE
    16 Jun 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.